Regen BioPharma, Inc.
RGBP
$0.0548
$0.00479.38%
OTC PK
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 1,700.00% | -85.71% | -98.87% | -20.87% | -37.27% |
| Total Receivables | 22.40% | 28.87% | 41.43% | 69.02% | 222.76% |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | -99.42% | -20.22% | 174.79% | 350.00% | 4.00% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | -12.67% | 8.63% | 4.92% | 23.90% | -13.26% |
|
|
|||||
| Total Current Assets | -12.67% | 8.63% | 4.92% | 23.90% | -13.26% |
| Net Property, Plant & Equipment | -- | -- | -- | -- | -- |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | -- | -- |
| Total Assets | -11.44% | 7.77% | 4.35% | 20.88% | -11.72% |
|
|
|||||
| Total Accounts Payable | -6.39% | 21.21% | 1.02% | -1.34% | -32.58% |
| Total Accrued Expenses | 2.62% | 2.58% | 0.15% | 1.07% | -1.08% |
| Short-term Debt | 95.72% | -63.53% | 34.49% | 336.65% | 0.00% |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 1.71% | 48.95% | 0.00% | 0.00% | -1.96% |
| Total Finance Division Other Current Liabilities | -4.90% | 13.61% | -1.19% | -1.06% | -1.06% |
| Total Other Current Liabilities | -4.90% | 13.61% | -1.19% | -1.06% | -1.06% |
| Total Current Liabilities | -0.04% | 9.29% | 0.82% | 2.99% | -1.41% |
|
|
|||||
| Total Current Liabilities | -0.04% | 9.29% | 0.82% | 2.99% | -1.41% |
| Long-Term Debt | -- | -- | -- | -- | -6.69% |
| Short-term Debt | 95.72% | -63.53% | 34.49% | 336.65% | 0.00% |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | -0.04% | 9.29% | 0.82% | 0.21% | -1.56% |
|
|
|||||
| Common Stock & APIC | 0.00% | 0.23% | 1.50% | 0.99% | 1.27% |
| Retained Earnings | -0.09% | -1.53% | -1.30% | -0.64% | -0.61% |
| Treasury Stock & Other | 0.00% | -- | -- | -- | -- |
| Total Common Equity | -0.34% | -9.34% | -0.72% | 0.35% | 1.25% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | 0.00% | 0.00% | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | 0.00% | 0.00% | -- | -- | -- |
|
|
|||||
| Total Common Equity | -0.34% | -9.34% | -0.72% | 0.35% | 1.25% |
| Total Preferred Equity | 0.00% | 0.00% | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -0.34% | -9.34% | -0.70% | 0.35% | 1.25% |
|
|
|||||